2m 2m 2m 2m 2m 2m 2m
BETA BIONICS (BBNX)
NASDAQ
$19.35+$0.01 (+0.05%)
Price as of Oct 22, 2026 7:30 PM EDT- $992.6MMarket Cap
- -13.29%1-Year Change
- Medical DevicesIndustry
BETA BIONICS (BBNX)
$19.35+$0.01 (+0.05%)
BBNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.34 | ||
Change | +$0.66 (+3.72%) | ||
Open | $18.40 | ||
High | $19.38 | ||
Low | $18.23 | ||
Previous Close | $18.40 | ||
Volume | 685,201 | ||
30-Day Average Volume | 1,100,253 | ||
1-Week Change | 9.07% | ||
1-Month Change | -16.52% | ||
1-Year Change | -13.29% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 53.9M | ||
Total Assets | $292.4M | ||
Market Cap | $992.6M | ||
Enterprise Value | $948.3M | ||
Period: QTR TTM FY | |||
Revenue | $32.0M | ||
Net Income | -$23.4M | ||
Free Cash Flow | -$15.7M | ||
EBIT | -$23.4M | ||
EBITDA | -$22.7M | ||
Net Working Capital | $205.0M | ||
EPS | -$0.53 | ||
Enterprise Value/EBITDA | -42 | ||
Enterprise Value/Revenue | 30 | ||
P/B | 4 | ||
P/E | -35 | ||
PEG | 4 | ||
Price/Free Cash Flow | -63 | ||
Price/Operating Cash Flow | -68 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue